MedPath

A study to compare effectiveness of LM scale potency versus centesimal scale potency of homoeopathic medicine in modifying susceptibility of children with ADHD

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Registration Number
CTRI/2021/07/034918
Lead Sponsor
irav Rajnikant Rughani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ADHD with other physical co-morbidity.

If child is taking other medical treatment then it must be pass minimum 3 months and the effect must be calculated before homoeopathic treatment started.

If child is on any other therapy like Behaviour therapy, physiotherapy, occupational therapy then we will continue it but, it must be pass 6 months and assessment of changes with that therapy will be evaluated before of the intervention of homoeopathic treatment then only that child will included in the study.

Exclusion Criteria

Epilepsy and other neuro-biological illness which can affect the children hyperactive behaviour will be excluded for the study.

Children, who have recent history of onset of other mode of therapy that have direct effect on modification of hyperactive behaviour of child will not be taken in for study.

If children are suffering with other co-morbidity with ADHD like Autism spectrum disorder, history of drug abuse, seizure, conduct disorder, oppositional defiant disorder, mood disorder (childhood depression), tics disorder and anxiety disorder will not be taken into study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparing the effectiveness of potency (centesimal scale versus LM scale) in modifying the susceptibility of children suffering with ADHD. <br/ ><br>To understand the modification of various facets of ADHD (Hyperactivity, Attention span, impulsivity) in children. <br/ ><br>To understand the state of susceptibility (Low, Moderate & high) of child and evaluate the overall improvement in it.Timepoint: 2 year 6 months
Secondary Outcome Measures
NameTimeMethod
To analyze the differences in improvement of both the group in general and characterize the susceptibility. <br/ ><br>To understand the modification of Adaptation, Academic performance, social and occupational functioning of ADHD children. <br/ ><br>To evaluate the therapeutic response at a global level (growth and development, recurring physical complaints etc.) and understand the improvement in susceptibility.Timepoint: 2 years and 6 months
© Copyright 2025. All Rights Reserved by MedPath